Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01713933 · ClinicalTrials.gov registry record · NA
Evaluation of the Ulthera® System for Treatment of the Brachia
A NA study, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT01713933 is a NA study that has completed, run by Ulthera. The registered enrollment target is 37 participants.
The verdict
NCT01713933, a NA study, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
This study is an evaluation of the Ulthera® System used to treat the upper arms for improvement of brachial ptosis. All enrolled subjects will receive one bilateral upper arm treatment. Follow-up visits will occur at 60, 90 and 180 days post-treatment.
Interventions
- DEVICE Ulthera® System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01713933
The ClinicalTrials.gov registry entry for NCT01713933 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ulthera® System is the first listed.
NCT01713933 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01713933 about?
NCT01713933 is a clinical study titled "Evaluation of the Ulthera® System for Treatment of the Brachia". This study is an evaluation of the Ulthera® System used to treat the upper arms for improvement of brachial ptosis. All enrolled subjects will receive one bilateral upper arm treatment. Follow-up visits will occur at 60, 90 and 180 days post-treatment.
What is the current status of trial NCT01713933?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2011-06. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01713933?
The interventions under investigation include: Ulthera® System (DEVICE).
Who is sponsoring clinical trial NCT01713933?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.